1. Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia.
- Author
-
Oyofo BA, Subekti DS, Svennerholm AM, Machpud NN, Tjaniadi P, Komalarini TS, Setiawan B, Campbell JR, Corwin AL, and Lesmana M
- Subjects
- Adolescent, Adult, Case-Control Studies, Child, Child, Preschool, Diarrhea epidemiology, Enzyme-Linked Immunosorbent Assay, Escherichia coli isolation & purification, Escherichia coli pathogenicity, Escherichia coli Infections epidemiology, Feces microbiology, Female, Gangliosides, Humans, Immunoblotting, Indonesia epidemiology, Infant, Male, Middle Aged, Bacterial Proteins analysis, Bacterial Toxins analysis, Diarrhea microbiology, Enterotoxins analysis, Escherichia coli immunology, Escherichia coli Infections microbiology, Escherichia coli Proteins, Fimbriae Proteins
- Abstract
Infection caused by enterotoxigenic Escherichia coli (ETEC) poses a serious health problem among children and adults in developing countries. Colonization of the small intestinal mucosa by ETEC strains is mediated by antigenically specific fimbriae, also known as colonization factor antigens (CFA). The significance of this study arises from reports that active and passive immunization with ETEC strains harboring CFAs has previously been shown to induce protective immunity against diarrhea in animal models. The aim of this study was to determine toxin-associated CFAs of ETEC isolated from a diarrheal disease case-control study in Jakarta, Indonesia. Thirteen hundred and twenty-three diarrheic and control patients with lactose-fermenting colonies were screened by ganglioside GM1-enzyme-linked immunosorbent assay (GM1-ELISA) for heat-labile (LT) and heat-stable (ST) toxins. Two hundred and forty-six (19%) ETEC isolates identified by GM1-ELISA for the LT/ST toxins were screened for CFAs by Dot blot assay using monoclonal antibodies against CFA/I, II, and IV and against the putative colonization antigens (PCF) PCFO159, PCFO166, CS7, and CS17. Of the 246 ETEC isolates, 177 (72%) elaborated ST, 56 (23%) produced LT, while 13 (5%) elicited both the ST and LT toxins. CFA testing of the 246 ETEC isolates showed that 21 (8%) expressed CFA/I, 3 (1%) exhibited CFA/II, 14 (6%) elaborated CFA/IV, while 7 (3%) expressed PCFO159 and PCFO159 plus CS5. No CFAs or PCFs could be associated with 201 (82%) of the ETEC strains. This report documents the types of CFAs associated with ETEC strains in Jakarta, Indonesia. These data may help current research efforts on the development of CFA-based vaccines for humans against ETEC and provide additional information for future ETEC vaccine trials in Southeast Asia.
- Published
- 2001
- Full Text
- View/download PDF